Iodine (as iodide) is widely but unevenly distributed in the earth’s environment. In many regions, leaching from glaciations, flooding, and erosion have depleted surface soils of iodide, and most iodide is found in the oceans. Iodine cycling in many regions is slow and incomplete, leaving soils and drinking water iodine depleted. Iodine deficiency in populations residing in low-iodine areas will persist until iodine enters the food chain through addition of iodine to foods (e.g., iodization of salt) or dietary diversification introduces foods produced outside the iodine-deficient area.
In healthy adults, the absorption of dietary iodine is >90% (1). Iodine is cleared from the circulation mainly by the thyroid and kidney, and although renal iodine clearance is fairly constant, thyroid clearance varies with iodine intake. In iodine-sufficient areas, the adult thyroid traps ∼60 μg of iodine/d to balance losses and maintain thyroid hormone synthesis. The body of a healthy adult contains 10 to 20 mg of iodine, of which 70 to 80% is in the thyroid. Iodine is used to build thyroid hormones, which are essential for mammalian life. The thyroid releases thyroid hormone into the circulation, and hormone degradation in the periphery releases iodine that enters the plasma iodine pool and can be taken up by the thyroid or excreted by the kidney. More than 90% of ingested iodine is ultimately excreted in the urine.
Deficiency
Iodine deficiency has multiple adverse effects on growth and development in animals and humans. These are collectively termed the “iodine deficiency disorders” (Table 1) and are one of the most important and common human diseases (2). They result from inadequate thyroid hormone production due to lack of sufficient iodine.
Table 1.
Iodine deficiency disorders, by age group
Age group | Health consequences |
All ages | Goiter |
Increased susceptibility of the thyroid gland to nuclear radiation | |
Fetus | Abortion |
Stillbirth | |
Congenital anomalies | |
Perinatal mortality | |
Neonate | Infant mortality |
Endemic cretinism | |
Child and adolescent | Impaired mental function |
Delayed physical development | |
Adults | Impaired mental function |
Reduced work productivity | |
Toxic nodular goiter, iodine-induced hyperthyroidism | |
Increased occurrence of hypothyroidism in moderate-to-severe iodine deficiency, decreased occurrence of hypothyroidism in mild-to-moderate iodine deficiency |
The global efforts to control iodine deficiency have been remarkably successful. Although severe endemic goiter has largely disappeared in most parts of the world, mild to moderate iodine deficiency continues to affect 32 countries, more than half of them in the industrialized world (including the United Kingdom and Australia), mainly due to reluctance of the food industry to use iodized salt (3). Ensuring sustainability in countries with successful programs requires regular surveillance and occasional adjustments to the iodine content in salt.
Diet recommendations
Various countries have established nutrient recommendations, including iodine. For the United States and Canada, the Institute of Medicine established Dietary Reference Intakes (DRIs) for iodine, and specifically an Adequate Intake for Infants and an Estimated Average Requirement (EAR) and Recommended Dietary Allowance (RDA) for children, adolescents, and adults (Table 2) (4). The WHO established Recommended Nutrient Intakes (RNIs) that cover the needs of nearly all healthy individuals for a specific life-stage group (Table 2) (5).
Table 2.
Recommendations for iodine intake by age or life-stage group1
US Institute of Medicine |
||||
Life-stage group | EAR2 | AI3 or RDA4 | Life-stage group | WHO RNI |
μg/d | μg/d | |||
Infants aged 0–12 mo | — | 110–130 | Children aged 0–5 y | 90 |
Children aged 1–8 y | 65 | 90 | Children aged 6–12 y | 120 |
Children aged 9–13 y | 73 | 120 | ||
Adults aged ≥14 y | 95 | 150 | Adults aged >12 y | 150 |
Pregnancy | 160 | 220 | Pregnancy | 250 |
Lactation | 200 | 290 | Lactation | 250 |
AI, Adequate Intake; EAR, Estimated Average Requirement; RDA, Recommended Dietary Allowance; RNI, Recommended Nutrient Intake.
EAR is the average daily nutrient intake level estimated to meet the requirement of half of healthy individuals in a particular life-stage and sex group.
AI is a recommended daily intake level that is expected to meet or exceed the amount to meet the requirement in essentially all individuals of a specific life-stage and sex group.
RDA is the average daily intake level sufficient to meet the requirement of nearly all (97–98%) healthy individuals in a particular life-stage and sex group.
Food sources
The naturally occurring iodine content of most foods and beverages is low. Foods of marine origin have a higher iodine content because iodine in seawater is concentrated in marine plants and animals. In many countries, use of iodized salt in households during cooking and consumption provides additional iodine.
In the United States, the median intake of iodine from food in 2003–2004 was estimated to be ∼20 to 285 μg/d for men and 145 to 200 μg/d for women (6). Major dietary sources of iodine in the United States are dairy products and whole grains (6). There has been concern about the presence of perchlorate in foods and drinking water because perchlorate inhibits the uptake of iodine in the thyroid gland. However, adverse effects in humans at the levels found in food have not been demonstrated.
Clinical uses
Iodine-based disinfectants are commonly used in clinical settings.
Toxicity
As salt iodization spreads across the globe, overiodized salt has contributed to excess iodine intakes in a number of countries and regions, and both iodine deficiency and excess can damage health. European (7) and US (5) expert committees have recommended Tolerable Upper Intake Levels for iodine (Table 3), but they caution that individuals with chronic iodine deficiency may respond adversely to intakes lower than these levels. In monitoring populations who consume iodized salt, the WHO recommendations for the median urinary iodine concentration (UIC) that indicates more-than-adequate and excess iodine intake in school-age children are 200–299 μg/L and >300 μg/L, respectively, and the median UIC that indicates excess iodine intake in pregnant women is >500 μg/L (1).
Table 3.
Tolerable Upper Intake Levels for iodine
Age group1 | European Commission/Scientific Committee on Food (5) | US Institute of Medicine (4) |
μg/d | ||
1–3 y | 200 | 200 |
4–6 y (4–8 y) | 250 | 300 |
7–10 y (9–13 y) | 300 | 600 |
11–14 y | 450 | — |
15–17 y (14–18 y) | 500 | 900 |
Adult | 600 | 1100 |
Pregnant and lactating women | 600 | 1100 |
Age categories in parenthesis are for the Tolerable Upper Intake Level defined by US Institute of Medicine (4).
Recent research
Current activities and future research priorities in the field of iodine nutrition include the following (8):
Validation/optimization of current UIC cutoffs for vulnerable groups, such as in pregnancy and infancy, using balance studies and functional biomarkers
Personalization of iodine requirements based on age, sex, ethnicity, environment, and health status
Development of robust, field-friendly functional biomarkers of thyroid status, including paper-based diagnostics, that respond to varying levels of iodine exposure
Validation of the extrapolation from the UIC to iodine intakes and application of the EAR cut-point model to allow national programs to derive accurate information on the prevalence of low iodine intakes in the population and to quantify the necessary increase in iodine intakes to ensure sufficiency in the population
Coordination of public health campaigns to reduce salt intake with iodized salt programs
Examination of the role of varying iodine intake on the incidence of autoimmune thyroid disease and papillary thyroid cancer
Iodine and its potential role in the antioxidant and immune response
For further information
Zimmermann MB. Iodine deficiency and endemic cretinism. In: Braverman L, Cooper DS, editors, Werner & Ingbars’s the thyroid, a fundamental and clinical text. 10th ed. Philadelphia: Lippincott, Williams & Wilkins; 2013. p. 217–41.
Zimmermann MB. Iodine and iodine deficiency disorders. In: Erdman JW, MacDonald IA, Zeisel SH, editors. Present knowledge in nutrition. 10th ed. Oxford (UK): ILSI, Wiley Blackwell; 2012. p. 554–66.
Institute of Medicine. Dietary Reference Intakes: the essential guide to nutrient requirements. Washington: The National Academies Press; 2006.
Literature Cited
- 1.Zimmermann MB. Iodine deficiency. Endocr Rev. 2009;30:376–408 [DOI] [PubMed] [Google Scholar]
- 2.World Health Organization; United Nations Children's Fund; International Council for the Control of Iodine Deficiency Disorders. Assessment of iodine deficiency disorders and monitoring their elimination: a guide for programme managers. 3rd ed. Geneva: WHO; 2007.
- 3.Andersson M, Karumbunathan V, Zimmermann MB. Global iodine status in 2011 and trends over the past decade. J Nutr. 2012;142:744–50 [DOI] [PubMed] [Google Scholar]
- 4.Institute of Medicine; Academy of Sciences. Dietary Reference Intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium and zinc. Washington: National Academy Press; 2001. [PubMed]
- 5.World Health Organization; International Council for the Control of the Iodine Deficiency Disorders; United Nations Childrens Fund. Assessment of the iodine deficiency disorders and monitoring their elimination. Geneva: WHO; 2007.
- 6.Murray CW, Egan SK, Kim H, Beru N, Bolger PM. US Food and Drug Administration’s Total Diet Study: dietary intake of perchlorate and iodine. J Expo Sci Environ Epidemiol. 2008;18:571–80 [DOI] [PubMed] [Google Scholar]
- 7.Scientific Committee on Food; Health and Consumer Protection Directorate-General. Opinion of the Scientific Committee on Food on the Tolerable Upper Intake Level of iodine. SCF/CS/NUT/UPPLEV/26 Final. Brussels: European Commission; 2002.
- 8.Zimmermann MB, Andersson M. Assessment of iodine nutrition in populations: past, present, and future. Nutr Rev. 2012;70:553–70 [DOI] [PubMed] [Google Scholar]